Abstract
Delayed union and non-union are widespread complications of bone fracture healing which are worse in cases of concomitant chronic diseases (diabetes mellitus, alcoholism, etc.). Osteonecrosis of different etiology is another cause of persistent bone defects. In the current research, we tested gene-activated grafts (GAGs) carrying dual expression cassette plasmid constructs encoding human vascular endothelial growth factor A (VEGF-A) and bone morphogenetic protein 2 (BMP2) genes. We modeled a thighbone diaphyseal defect on male Wistar rats and tested either GAG based on collagen and hydroxyapatite granules (Collapol CP-3) or GAG octacalcium phosphate (OCP) grafts. Histological examination revealed significant increases in vascularization and bone tissue formation in the GAG Collapol CP-3 graft experimental group, while neither the OCP nor the GAG OCP group showed a positive effect on callus formation. We conclude that GAG Collapol CP-3 bone grafts are a potential therapeutic solution for bone tissue regeneration and further clinical studies are required.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
